Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2025-12-25 @ 12:45 AM
NCT ID:
NCT03682367
Eligibility Criteria:
Inclusion Criteria:
* Patients undergoing major head and neck surgery with concomitant free flap reconstruction surgery at UCDMC (oncology and non-oncologic): There will be two groups. Group 1 will include reconstruction with fibula free flap only. Group 2 will include any other free flap reconstruction, including scapular free flap, radial forearm free flap, anterolateral thigh free flap, anteromedial thigh free flap, and latissimus dorsi free flap.
* Patients naïve to gabapentin
* Adult patients \>18 years of age and able to consent
Exclusion Criteria:
* Patients who are already taking scheduled gabapentin
* Patients allergic to gabapentin
* Chronic opioid use not from active head and neck cancer
* Illicit drug use (per report)
* Patients with known renal compromise, such that Creatinine clearance is \< 30
* Patient with known hepatic insufficiency or cirrhosis
* Adults unable to consent
* Individuals less than 18 years old
* Pregnant women
* Prisoners
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03682367
Study Brief:
Protocol Section:
NCT03682367